Ibnsina Pharma Revenue

Ibnsina Pharma had revenue of 17.04B EGP in the quarter ending March 31, 2025, with 61.17% growth. This brings the company's revenue in the last twelve months to 62.31B, up 65.36% year-over-year. In the year 2024, Ibnsina Pharma had annual revenue of 55.84B with 64.49% growth.

Revenue (ttm)

62.31B

Revenue Growth

+65.36%

P/S Ratio

0.15

Revenue / Employee

11.33M

Employees

5,500

Market Cap

9.55B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	55.84B	21.89B	64.49%
Dec 31, 2023	33.95B	11.68B	52.48%
Dec 31, 2022	22.26B	531.66M	2.45%
Dec 31, 2021	21.73B	3.05B	16.35%
Dec 31, 2020	18.68B	2.08B	12.52%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Commercial International Bank Egypt (CIB) S.A.E.	107.76B
El Sewedy Electric Company	246.12B
Talaat Moustafa Group Holding	45.30B
Eastern Company S.A.E	34.08B
Misr Fertilizer Production Company	21.20B
Alexandria Container&Cargo Handling Company	8.41B
Egypt Aluminum	42.42B
Telecom Egypt Company	89.35B

Revenue Rankings